CLAUDIA MACIAS: Open Payments
NPI 1508496167 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 12 payments from 7 companies in 2025. Trend: 2023 $124 · 2024 $309 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $158 |
| Medtronic, Inc. | 1 | $129 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $35 |
| Amgen Inc. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: SYMPLICITY G3, UPTRAVI, Ozempic, Wegovy, VERQUVO, AMVUTTRA, REPATHA, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
